Jones Financial Companies’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $132K | Sell |
878
-18
| -2% | -$2.7K | ﹤0.01% | 1825 |
|
|
2025
Q1 | $139K | Buy |
896
+255
| +40% | +$39.7K | ﹤0.01% | 1632 |
|
|
2024
Q4 | $118K | Buy |
641
+90
| +16% | +$16.6K | ﹤0.01% | 1563 |
|
|
2024
Q3 | $109K | Buy |
551
+266
| +93% | +$52.7K | ﹤0.01% | 1362 |
|
|
2024
Q2 | $58.9K | Buy |
285
+279
| +4,650% | +$57.6K | ﹤0.01% | 1191 |
|
|
2024
Q1 | $1.63K | Sell |
6
-16
| -73% | -$4.34K | ﹤0.01% | 1274 |
|
|
2023
Q4 | $5.2K | Sell |
22
-9
| -29% | -$2.13K | ﹤0.01% | 757 |
|
|
2023
Q3 | $6.08K | Buy |
31
+6
| +24% | +$1.18K | ﹤0.01% | 507 |
|
|
2023
Q2 | $5.26K | Hold |
25
| – | – | ﹤0.01% | 490 |
|
|
2023
Q1 | $5.05K | Hold |
25
| – | – | ﹤0.01% | 519 |
|
|
2022
Q4 | $5K | Hold |
25
| – | – | ﹤0.01% | 536 |
|
|
2022
Q3 | $5K | Hold |
25
| – | – | ﹤0.01% | 473 |
|
|
2022
Q2 | $5K | Hold |
25
| – | – | ﹤0.01% | 541 |
|
|
2022
Q1 | $7K | Hold |
25
| – | – | ﹤0.01% | 543 |
|
|
2021
Q4 | $9K | Sell |
25
-50
| -67% | -$18K | ﹤0.01% | 559 |
|
|
2021
Q3 | $31K | Buy |
75
+50
| +200% | +$20.7K | ﹤0.01% | 380 |
|
|
2021
Q2 | $9K | Hold |
25
| – | – | ﹤0.01% | 478 |
|
|
2021
Q1 | $7K | Buy |
+25
| New | +$7K | ﹤0.01% | 571 |
|